A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a multi-center clinical trial led by the Icahn School of Medicine at Mount Sinai.
UnitedHealth gives timeline for Change restoration: payments up by late next week
Change Healthcare’s parent company said it’ll have its electronic payment function up and running by late next week after a February cyberattack took many of
March 8, 2024